However, since SARS-CoV-infected alveolar epithelial cells were found to produce type I IFN mRNA in vitro, and individual differences in IFN signalling may partially explain variability in the severity of COVID-19 symptoms [97–99], it is interesting to consider how epithelial-cell IFN production may impact the course of infection. This evidence concerns the gene IFNA1 and COVID-19.